Cell and molecular biology of simian virus 40: Implications for human infections and disease

Journal of the National Cancer Institute

Volumn 91, Issue 2, 1999, Pages 119-134

  Butel, Janet S ^a   Lednicky, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; DNA DETERMINATION; DNA STRUCTURE; INFECTION SENSITIVITY; MOLECULAR BIOLOGY; MONKEY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; STRAIN DIFFERENCE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS MORPHOLOGY; VIRUS REPLICATION;

EID: 0033585417     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.2.119     Document Type: Review

References (134)

1. Cole CN. Polyomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, et al., editors. Fields virology, 3rd ed. Vol 2. Philadelphia (PA): Lippincott-Raven; 1996. p. 1997-2025.
2. Butel JS. Simian virus 40. In: Webster RG, Granoff A, editors. Encyclopedia of virology. Vol 3. San Diego (CA): Academic Press; 1994. p. 1322-9.
3. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 1997;15:1877-88.
4. 40. Proc Soc Exp Biol Med 1960;105:420-7.
5. Fraumeni JF Jr, Ederer F, Miller RW. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 1963;185;713-8.
6. Lewis AM Jr. Experience with SV40 and adenovirus-SV40 hybrids. Biohazards in biological research. New York (NY): Cold Spring Harbor Laboratory Press; 1973. p. 96-113.
7. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.
8. Geissler E. SV40 and human brain tumors. Prog Med Virol 1990;37: 211-22.
9. Eddy BE, Borman GS, Grubbs GE, Young RD. Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 1962;17:65-75.
10. 40. Proc Soc Exp Biol Med 1962;109:649-60.
11. Butel JS, Tevethia SS, Melnick JL. Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res 1972;15:1-55.
12. Mortimer EA Jr, Lepow ML. Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981;305:1517-8.
13. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
14. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998;279:292-5.
15. Fisher SG. SV40-contaminated poliovirus vaccine and childhood cancer risk [letter]. JAMA 1998;279:1527-8.
16. Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, et al., editors. Virus taxonomy: classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses. Arch Virol 1995: Suppl 10.
17. Pipas JM. Common and unique features of T antigens encoded by the polyomavirus group. J Virol 1992;66:3979-85.
18. Shah KV. Polyomaviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, et al., editors. Fields virology. 3rd ed. Vol 2. Philadelphia (PA): Lippincott-Raven; 1996. p. 2027-43.
19. Tevethia SS. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol Biol Med 1990;7:83-96.
20. Frisque RJ. JC and BK viruses. In: Webster RG. Granoff A, editors. Encyclopedia of virology. Vol. 2. San Diego (CA): Academic Press; 1994. p. 752-7.
21. Stewart AR, Lednicky JA, Butel JS. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol 1998;4:182-93.
22. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 1995;212:710-7.
23. Lednicky JA, Butel JS. Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol 1997;78(Pt 7): 1697-705.
24. Lednicky JA, Stewart AR, Jenkins JJ 3rd, Finegold MJ. Butel JS. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer 1997;72:791-800.
25. Ilyinskii PO, Daniel MD, Horvath CJ. Desrosiers RC. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 1992;66:6353-60.
26. Lednicky JA, Arrington AS, Stewart AR, Dai XM, Wong C, Jafar S, et al. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol 1998;72:3980-90.
27. Newman JS, Baskin GB, Frisque RJ. Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus monkeys. J Neurovirol 1998;4:394-406.
28. Lednicky JA, Wong C, Butel JS. Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res 1995;35:143-53.
29. Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC. Structure of simian virus 40 at 3.8-A resolution. Nature 1991;354: 278-84.
30. Chang D, Liou ZM, Ou WC, Wang KZ, Wang M, Fung CY, et al. Production of the antigen and the antibody of the JC virus major capsid protein VPI. J Virol Methods 1996;59:177-87.
31. Stewart AR, Lednicky JA, Benzick US, Tevethia MJ, Butel JS. Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 1996;221:355-61.
32. Pipas JM. Mutations near the carboxyl terminus of the simian virus 40 large tumor antigen alter viral host range. J Virol 1985;54:569-75.
33. Tornow J, Polvino-Bodnar M, Santangelo G, Cole CN. Two separable functional domains of simian virus 40 large T antigen: carboxyl-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis. J Virol 1985;53:415-24.
34. Fanning E. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol 1992;66:1289-93.
35. Spence SL, Pipas JM. Simian virus 40 large T antigen host range domain functions in virion assembly. J Virol 1994;68:4227-40.
36. Bright RK, Shearer MH, Kennedy RC. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes. Clin Exp Immunol 1994;96:491-9.
37. Ashkenazi A, Melnick JL. Induced latent infection of monkeys with vacuolating SV-40 papova virus: virus in kidneys and urine. Proc Soc Exp Biol Med 1962;111:367-72.
38. Sheffield WD. Strandberg JD, Braun L, Shah K, Kalter SS. Simian virus 40-associated fatal interstitial pneumonia and renal tubular necrosis in a rhesus monkey. J Infect Dis 1980;142:618-22.
39. Horvath CJ, Simon MA, Bergsagel DJ, Pauley DR, King NW, Garcea RL, et al. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol 1992;140:1431-40.
40. Holmberg CA, Gribble DH, Takemoto KK, Howley PM, Espana C, Osburn BI. Isolation of simian virus 40 from rhesus monkeys (Macaca mulatta) with spontaneous progressive multifocal leukoencephalopathy. J Infect Dis 1977;136:593-6.
41. Hurley JP, Ilyinskii PO, Horvath CJ, Simon MA. A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus. J Med Primatol 1997;26:172-80.
42. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996; 56:4820-5.
43. Kirschstein RL, Gerber P. Ependymomas produced after intracerebral inoculation of SV40 into newborn hamsters. Nature 1962;195:299-300.
44. Diamandopoulos GT. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 1973;50:1347-65.
45. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524-33.
46. Brinster R, Chen H, Messing A, van Dyke T, Levine A, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-79.
47. Hanahan D. Transgenic mice as probes into complex systems. Science 1989;246:1265-75.
48. Adams JM, Cory S. Transgenic models of tumor development. Science 1991;254:1161-7.
49. Conzen SD, Cole CN. The transforming proteins of simian virus 40. Semin Virol 1994;5:349-56.
50. Fanning E, Knippers R. Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 1992;61:55-85.
51. Neil JC, Cameron ER, Baxter EW. p53 and tumour viruses: catching the guardian off-guard. Trends Microbiol 1997;5:115-20.
52. Campbell KS, Mullane KP, Aksoy IA, Stubdal H, Zalvide J, Pipas JM, et al. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev 1997;11:1098-110.
53. Kelley WL, Georgopoulos C. The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc Natl Acad Sci U S A 1997;94:3679-84.
54. Srinivasan A, McClellan AJ, Vartikar J, Marks I, Cantalupo P, Li Y, et al. The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol 1997;17:4761-73.
55. Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM, DeCaprio JA. Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol 1997;17: 4979-90.
56. Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994;64:25-85.
57. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998;273:1-4.
58. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
59. Brugge JS, Butel JS. Role of the simian virus 40 gene A function in maintenance of transformation. J Virol 1975;15:619-35.
60. Martin RG, Chou JY. Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J Virol 1975;15: 599-612.
61. Tegtmeyer P. Function of simian virus 40 gene A in transforming infection. J Virol 1975;15:613-8.
62. Levine AJ. Oncogenes of DNA tumor viruses. Cancer Res 1988;48: 493-6.
63. Bishop JM. Viral oncogenes. Cell 1985;42:23-38.
64. Martin RG, Setlow VP, Edwards CA, Vembu D. The roles of the simian virus 40 tumor antigens in transformation of Chinese hamster lung cells. Cell 1979;17:635-43.
65. Cicala C, Pompetti F, Nguyen P, Dixon K, Levine AS, Carbone M. SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. Virology 1992;190:475-9.
66. Butel JS, Jarvis DL. The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochim Biophys Acta 1986;865:171-95.
67. Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen RF, et al. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res 1989;49:6108-17.
68. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 1996;273:1384-6.
69. Symonds HS, McCarthy SA, Chen J, Pipas JM, Van Dyke T. Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant. Mol Cell Biol 1993;13:3255-65.
70. Saenz Robles MT, Symonds H, Chen J, Van Dyke T. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol 1994;14:2686-98.
71. Chen J, Tobin GJ, Pipas JM, Van Dyke T. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 1992;7:1167-75.
72. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncogen 1994;5:331-57.
73. Huschtscha LI, Holliday R. Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci 1983; 63:77-99.
74. Shay JW, Wright WE. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 1989;184:109-18.
75. Shay JW, Van Der Haegen BA, Ying Y, Wright WE. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 1993;209:45-52.
76. Price TN, Moorwood K, James MR, Burke JF, Mayne LV. Cell cycle progression, morphology and contact inhibition are regulated by the amount of SV40 T antigen in immortal human cells. Oncogene 1994;9: 2897-904.
77. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991;196:33-9.
78. Radna RL, Caton Y, Jha KK, Kaplan P, Li G, Traganos F, et al. Growth of immortal simian virus 40 tsA-transformed human fibroblasts is temperature dependent. Mol Cell Biol 1989;9:3093-6.
79. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989;9:3088-92.
80. Resnick-Silverman L, Pang Z, Li G, Jha KK, Ozer HL. Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts. J Virol 1991;65:2845-52.
81. O'Neill FJ, Frisque RJ, Xu X, Hu YX, Carney H. Immortalization of human cells by mutant and chimeric primate polyomavirus T-antigen genes. Oncogene 1995;10:1131-9.
82. Shein HM, Enders JF. Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissues. Proc Soc Exp Biol Med 1962;109:495-500.
83. O'Neill FJ, Carroll D. Amplification of papovavirus defectives during serial low multiplicity infections. Virology 1981;112:800-3.
84. O'Neill FJ, Xu XL, Miller TH. Host range determinant in the late region of SV40 and RF virus affecting growth in human cells. Intervirology 1990;31:175-87.
85. Li JJ, Kelly TJ. Simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A 1984;81:6973-7.
86. Murakami Y, Wobbe CR, Weissbach L, Dean FB, Hurwitz J. Role of DNA polymerase α and DNA primase in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A 1986;83:2869-73.
87. Waga S, Bauer G, Stillman B. Reconstitution of complete SV40 DNA replication with purified replication factors. J Biol Chem 1994;269: 10923-34.
88. Shein HM. Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia. J Neuropathol Exp Neurol 1967;26:60-76.
89. Deminie CA, Norkin LC. Simian virus 40 DNA replication correlates with expression of a particular subclass of T antigen in a human glial cell line. J Virol 1990;64:3760-9.
90. Lynch KJ, Haggerty S, Frisque RJ. DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 1994;204:819-22.
91. Melnick JL, Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962;109:965-8.
92. 40) by respiratory route. Proc Soc Exp Biol Med 1961;108:56-9.
93. Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein LJ, et al. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972;286: 385-90.
94. Hayashi T, Sumiyoshi A, Tanaka M, Araki S, Minamishima Y. Progressive multifocal leukoencephalopathy. A case report with special reference to SV40 etiology. Acta Pathol Jpn 1985;35:173-81.
95. Brandner G, Burger A, Neumann-Haefelin D, Reinke C, Helwig H. Isolation of simian virus 40 from a newborn child. J Clin Microbiol 1977; 5:250-2.
96. Sirken M, Brener B. Population characteristics and participation in the poliomyelitis vaccination program. Publ Hlth Monogr 1960;61:1-37.
97. Shah KV, Ozer HL, Pond HS, Palma LD, Murphy GP. SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 1971;231:448-9.
98. Shah KV, McCrumb FR Jr, Daniel RW, Ozer HL. Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 1972;48: 557-61.
99. Shah KV. Evidence for an SV40-related papovavirus infection of man. Am J Epidemiol 1972;95:199-206.
100. Horvath LB. SV40 neutralizing antibodies in the sera of man and experimental animals. Acta Virol 1972;16:141-6.
101. Zimmermann W, Scherneck S, Geissler E. Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA). Zentralbl Bakteriol Mikrobiol Hyg 1983;254:187-96.
102. Geissler E, Konzer P, Scherneck S, Zimmermann W. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol 1985;29:420-3.
103. Jafar S, Rodriguez-Barradas M, Graham DY, Butel JS. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 1998;54:276-84.
104. Brown P, Morris JA. Serologic response to BK Virus following human infection with SV40. Proc Soc Exp Biol Med 1976;152:130-1.
105. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975;102:331-40.
106. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973;128:784-7.
107. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973;127:467-70.
108. Hsiung GD, Fong CKY, Landry ML, editors. Hsiung's diagnostic virology. 4th ed. New Haven (CT): Yale University Press; 1994.
109. Woloschak M, Yu A, Post KD. Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction. Cancer 1995;76:490-6.
110. Galaleau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letourneux M, et al. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol 1998;184:252-7.
111. Meinke W, Goldstein DA, Smith RA. Simian virus 40-related DNA sequences in a human brain tumor. Neurology 1979;29:1590-4.
112. Geissler E, Scherneck S, Prokoph H, Zimmermann W, Staneczek W. SV40 in human brain tumors: risk factor or passenger? In: Giraldo G, Beth E, editors. The role of viruses in human cancer. Vol II. Amsterdam (The Netherlands): Elsevier; 1984. p. 265-79.
113. Tabuchi K, Kirsch WM, Low M, Gaskin D, Van Buskirk J, Maa S. Screening of human brain tumors for SV40-related T antigen. Int J Cancer 1978;21:12-7.
114. Ibelgaufts H, Jones KW. Papovavirus-related RNA sequences in human neurogenic tumours. Acta Neuropathol 1982;56:118-22.
115. Weiss AF, Portmann R, Fischer H, Simon J, Zang KD. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci U S A 1975;72:609-13.
116. Kneg P, Amtmann E, Jonas D, Fischer H, Zang K, Sauer G. Episomal simian virus 40 genomes in human brain tumors. Proc Natl Acad Sci U S A 1981;78:6446-50.
117. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326:988-93.
118. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781-90.
119. Pepper C, Jasani B, Navabi H, Wynford-Thomas D, Gibbs AR. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 1996;51:1074-6.
120. Cristaudo A, Vivaldi A, Sensales G, Guglielmi G, Ciancia E, Elisei R, et al. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-Ras, p21, and SV40. J Environ Pathol Toxicol Oncol 1995;14:29-34.
121. Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, et al. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 1996;5:473-5.
122. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908-12.
123. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 1997;3: 913-6.
124. Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, et al. SV40-like sequences in human bone tumors. Oncogene 1996;13: 527-35.
125. Pacini F, Vivaldi A, Santoro M, Fedele M, Fusco A, Romei C, et al. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 1998;16:665-9.
126. Krieg P, Scherer G. Cloning of SV40 genomes from human brain tumors. Virology 1984;138:336-40.
127. Scherneck S, Rudolph M, Geissler E, Vogel F, Lubbe L, Wahlte H, et al. Isolation of a SV40-like Papovavirus from a human glioblastoma. Int J Cancer 1979;24:523-31.
128. Soriano F, Shelburne CE, Gokcen M. Simian virus 40 in a human cancer. Nature 1974;249:421-4.
129. De Mattei M, Martini F, Tognon M, Serra M, Baldini N, Barbanti-Brodano G. Polyomavirus latency and human tumors [letter]. J Infect Dis 1994;169:1175-6.
130. Wiman KG, Klein G. An old acquaintance resurfaces in human mesothelioma [news]. Nat Med 1997;3:839-40.
131. Eckhart W. Polyomavirinae and their replication. In: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, et al., editors. Fields virology. 2nd ed. Vol 2. New York (NY): Raven Press; 1990. p. 1593-607.
132. Levine AJ. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 1990;177:419-26.
133. Evans AS, Mueller NE. Viruses and cancer: causal associations. Ann Epidemiol 1990;1:71-92.
134. Hill AB, Hill ID. Bradford Hill's principles of medical statistics. 12th ed. London (U.K.): Edward Arnold; 1991.